Biomarkers plays a major role in Oncology that are used in clinical research for risk assessment, differential diagnosis, determining nature of tumors, for screening purpose, to determine prognosis and drug dose-response to treatment. Biomarkers can predict behavior of tumor (benign/malignant), drug resistance. Biomarkers can establish the accuracy of diagnosis, can be associated to other investigations to suspect the type of Cancer.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: American association for Cancer research, American Society of Clinical Oncology, BASO-the association for Cancer surgery, Cent Pour Sang La Vie, French National Cancer Institute.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
